Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2021-12-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권) (2022.02)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by BNC Korea. It explicitly states it is a 'Correction Report' (정정신고) following a request from the Financial Supervisory Service (FSS). It details changes to the public offering schedule, subscription methods, and risk factors related to a capital increase (rights offering). This is a formal regulatory filing required for capital raising activities, which falls under the 'Regulatory Filings' category as it is a specific type of registration statement amendment.
2021-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or voting results, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given the nature of the announcement and the lack of a specific category for 'Record Date/Shareholder Register' notices, it falls under the general regulatory filing category.
2021-12-16 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It explicitly states it is a 'Correction Report' (정정신고) for a previously filed capital increase plan, detailing changes to dates, subscription schedules, and pricing methodologies. This falls under the category of announcements regarding capital structure changes and share issuance.
2021-12-16 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing a 'Capital Increase Decision' (유상증자결정). It outlines the terms of a rights offering, including share counts, pricing methods, subscription dates, and the role of the lead underwriter (SK Securities). This falls under the category of announcements regarding new share issues or capital changes.
2021-12-01 Korean
증권신고서(지분증권) (2022.01)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital increase (rights offering/public offering) by '한국비엔씨' (BNC Korea). It includes comprehensive sections on investment risks, business overview, and financial status, which are standard components of a formal securities registration filing. This type of document is a regulatory filing related to capital raising and does not fit into the other specific categories like 10-K or Earnings Release.
2021-12-01 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '전환사채권 발행결정' (Decision on Issuance of Convertible Bonds) submitted by Korea BNC. It details the terms of a convertible bond issuance, including conversion price adjustments, put/call options, and specific investor allocations. This type of document is a standard corporate disclosure regarding capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2021-11-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.